Product Description: Carbazomycin B is a bacterial metabolite and can be isolated from Streptomyces. Carbazomycin B is an antifungal and antibacterial agent. Carbazomycin B inhibits 5-lipoxygenase (5-LO) activity in extract from RBL-1 cell with the IC50 Of 1.5 µM[1]sup>[2]sup>[3]sup>[4].
Applications: COVID-19-immunoregulation
Formula: C15H15NO2
References: [1]Sakano K, et al. New antibiotics, carbazomycins A and B. I. Fermentation, extraction, purification and physico-chemical and biological properties. J Antibiot (Tokyo). 1980;33(7):683-689. /[2]Naid T, et al. Carbazomycins C, D, E and F, minor components of the carbazomycin complex. J Antibiot (Tokyo). 1987;40(2):157-164. /[3]Hook DJ, et al. Identification of the inhibitory activity of carbazomycins B and C against 5-lipoxygenase, a new activity for these compounds. J Antibiot (Tokyo). 1990 Oct;43(10):1347-8. /[4]Yamasaki K, Kaneda M, Watanabe K, et al. New antibiotics, carbazomycins A and B. III. Taxonomy and biosynthesis. J Antibiot (Tokyo). 1983;36(5):552-558.
CAS Number: 75139-38-7
Molecular Weight: 241.29
Research Area: Cancer; Infection
Target: Antibiotic;Bacterial;Lipoxygenase
English
Deutsch
